Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
Treating older people with diabetes is challenging due to multiple medical comorbidities that might interfere with patients' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback